AVITA Medical, Inc Health Care
Biotech Healthcare North America United Kingdom

$5.19 0.12 (2.37%)

High $5.29	Low $5.12	Trades 1,945	Turnover $3,576,754	Volume 686,116
30 June 2023 at 4:10pm

Market Cap (14-Sep) $417,512,448 (489th)	Close (30-Jun) $5.19 0 (0%)	Volume (30-Jun) 686,116	Shortsold (8-Sep) 118,402 (0.15%) (422nd)
52w High $3.08	52w Low $1.00	P/E 9.97	EPS -0.4
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 3+

Short Interest

ASIC data, 8 Sep 2026

% Shorted

0.15%

vs 0.15% prior report

Most Shorted Rank

422nd

of 694 shorted ASX stocks

Peak Short

10.06%

Nov 2020

Days to Cover

0.2

at 50d avg vol

View full short position history →

	Subject
	AVH AVH Ann: FDA Approves IDE Amendment to AVITA's Vitiligo Pivotal Study
	1 (current) 2 3
	AVH AVH Ann: AVITA to Announce Fiscal 4th Quarter 2021 Financial Results
	AVH AVH Ann: Change in substantial holding
	AVH AVH Ann: Statement of CDIs on issue - AVH
	AVH AVH Ann: Notification of cessation of securities - AVH
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appendix 4A
	AVH AVH Ann: Appendix 3H
	AVH AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Initial Director's Interest Notice - Jan Stern Reed
	AVH AVH Ann: Initial Director's Interest Notice - J. Corbett
	AVH AVH Ann: AVITA Medical Announces Inclusion in the Russell 3000 Index
	AVH AVH Ann: AVITA Medical Investor Briefing
	AVH AVH Ann: AVITA Announces Preliminary Q4 2021 Financial Results
	AVH AVH Ann: U.S. FDA Approves Expanded Use of the RECELL System
	AVH AVH Ann: Change of Director's Interest Notice - Michael Perry
	AVH AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appendix 4A
	AVH AVH Ann: Cleansing Notice under s708A(5)(e) of the Corporations Act
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: AVH Appoints Two New Non-Executive Members to the Board
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Avita Medical Reports Third Quarter 2021 Financial Results
	AVH AVH Ann: Financial Report for Fiscal Third Quarter 2021 Form 10Q
	AVH AVH Ann: Appendix 4A
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: AVITA to Announce Fiscal 3rd Quarter 2021 Financial Results
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: RECELL Data to be Presented at Boswick Symposium
	AVH AVH Ann: Appointment of Jeremy Curnock Cook to Audit Committee
	AVH AVH Ann: Appendix 4A
	AVH AVH Ann: 15 RECELL Abstracts Accepted at 53rd Annual ABA Meeting
	AVH AVH Ann: Change of Director's Interest Notice - Michael Perry
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appointment of Chief Financial Officer
	AVH AVH Ann: Form 10-K/A filed with the SEC
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Appendix 4A
	AVH AVH Ann: Appendix 3G
	AVH AVH Ann: Cleansing Notice under s708(5)(e) of the Corporations Act
	AVH AVH Ann: Closing of Offering of 3,214,250 Shares in Common Stock
	AVH AVH Ann: Prospectus Supplement
	AVH AVH Ann: Proposed issue of Securities - AVH
	AVH AVH Ann: Removal of Trading Halt Request
	AVH AVH Ann: Preliminary Prospectus Supplement
	AVH AVH Ann: Trading Halt

End of Day Prices

Date	Close	Volume	Change
14-Sep	$2.70	114,498	0.00 (0.00%)
11-Sep	$2.70	343,888	-0.08 (2.88%)
10-Sep	$2.78	325,257	-0.05 (1.77%)
09-Sep	$2.83	320,481	-0.17 (5.67%)
08-Sep	$3.00	483,944	-0.01 (0.33%)
07-Sep	$3.01	215,182	-0.01 (0.33%)
04-Sep	$3.02	257,101	+0.01 (0.33%)
03-Sep	$3.01	876,873	+0.21 (7.50%)
02-Sep	$2.80	297,685	+0.03 (1.08%)
01-Sep	$2.77	145,444	-0.02 (0.72%)
31-Aug	$2.79	258,761	-0.03 (1.06%)
28-Aug	$2.82	213,668	-0.05 (1.74%)
27-Aug	$2.87	345,288	-0.04 (1.37%)
26-Aug	$2.91	1,151,461	+0.17 (6.20%)
25-Aug	$2.74	273,375	-0.01 (0.36%)
4 up, 10 down, and 1 flat days

AVH AVITA Medical, Inc Health Care Biotech Healthcare North America United Kingdom

Short Interest

Followers

Prices

Announcements

End of Day Prices

AVITA Medical, Inc Health Care
Biotech Healthcare North America United Kingdom